# Ablaze Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ablaze-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.ablazepharma.com
- Total disclosed funding: $75M
- Latest round: Series A (Nov 29, 2021)
- Investors on record: 8

## About

Established in 2021 and based in Shanghai, China, Ablaze Pharmaceuticals is a biopharmaceutical company that focuses on research and development of radiotherapy drugs and Targeted Radiotherapy (TRT). The president and CEO Dr. Alex Qiao is the postdoctoral in biochemistry at the Massachusetts Institute of Technology, he co-founded and was CEO of NajingTech from 2008 to 2012 and has over 20 years of experience as an entrepreneur, business leader and technology innovator in the life sciences, biopharmaceutical and high-tech industries.

The company is main business is research and development of radiotherapy drugs and Targeted Radiotherapy (TRT), technology development, technology consulting, technology service, technology transfer in the fields of medical technology and biotechnology, and wholesale and retail of first-class medical equipment.

The company plans to use the series A funding for establish a leading pipeline of advanced TRT products for the treatment of solid tumors, build a leadership team, and establish a radiopharmaceutical infrastructure.

## Funding rounds

- Series A, Nov 29, 2021, $75M — Vivo Capital, VenBio, Advantech Capital, Pivotal Life Sciences, Nan Fung Life Sciences, Samsara BioCapital, Venrock Healthcare Capital Partners, RayzeBio, Inc.

## Investors

- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series A
- VenBio (https://capitalatlas.ai/funds/venbio) — Series A
- Advantech Capital (https://capitalatlas.ai/funds/advantech-capital) — Series A
- Pivotal Life Sciences (https://capitalatlas.ai/funds/pivotal-life-sciences) — Series A
- Nan Fung Life Sciences — Series A
- Samsara BioCapital (https://capitalatlas.ai/funds/samsara-biocapital) — Series A
- Venrock Healthcare Capital Partners (https://capitalatlas.ai/funds/venrock-healthcare-capital-partners) — Series A
- RayzeBio, Inc. — Series A